iollo - the AI Scientist
- Academic, tech transfer
- Biotech – industrial & Environmental
- Biotech or pharma, animal health
- Biotech or pharma, therapeutic R&D
- CMO, CRO
- Institute, hospital research
- IT, information
- Other products or services
- Other R&D services
- Biotech – food & agriculture
iollo is a Stanford spinout, co-founded with Prof. Michael Snyder and backed by Y Combinator. We developed Quinn, an AI scientist built to rapidly accelerate pharma and biotech discovery.
Quinn quickly integrates and analyzes complex multi-omics and clinical datasets, autonomously uncovering novel biology, actionable therapeutic targets, and robust mechanistic insights — compressing critical steps like target identification, lead optimization (biological and chemical), translational analysis, and risk assessment from months to days.
For biotech companies and pharma teams, Quinn streamlines data-driven decisions, reduces development risk, and optimizes strategic investments without the need for additional internal resources or headcount.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}